DialysisPPO Files Provisional Patent Application For Dialysis Cost Containment
DialysisPPO, a Pennsylvania Corporation providing cost containment solutions to the health plan market, has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) covering its business method that enables health plans to significantly low.
Interim Phase 2 Results Of Open-Label Clinical Trial Of Denosumab In Giant Cell Tumor Of Bone Demonstrated 87 Percent Response Rate
Amgen (NASDAQ:AMGN) announced interim results of an open-label Phase 2 study demonstrating a positive response rate to administration of denosumab in subjects with recurrent or unresectable giant cell tumor of bone. The study was presented at the 2008 American Society of Clinical Oncology (ASCO) annual meeting.
Pfizer Presents Overall Survival Data For Sutent trade; Versus Interferon-Alfa - First Treatment To Demonstrate Overall Survival Greater Than 2 Years
Results from a landmark study have shown that sunitinib (SUTENT™ ) has demonstrated overall survival greater than two years in patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer.
NARSAD Researchers Identify Specific Genes And Family Traits Linked To Schizophrenia, Bipolar Disorder And Depression
New findings from research supported by NARSAD, the world's leading charity dedicated to mental health research, and conducted by Harvard-affiliated scientists are providing important clues into how genes work to impair various aspects of attention, memory and perception -- the behaviors associated with many psychiatric illnesses, such as schizophrenia, bipolar disorder and depression.
Encouraging Findings From TNFerade TM Head And Neck Cancer Study Presented At ASCO
Encouraging data from GenVec, Inc.'s (Nasdaq:GNVC) Phase I clinical trial of TNFerade™ in patients with head and neck cancer were presented by study investigator Everett Vokes, M.D., University of Chicago, in a poster session at the annual meeting of the American Society for Clinical Oncology (ASCO) in Chicago, IL.
ClinPhone Completes Medicines And Healthcare Products Regulatory Agency MHRA Inspection
ClinPhone, the world's largest Clinical Technology Organization (CTO), has received the GCP Inspection Statement to complete the latest Inspection by the GCP Inspectorate of the Medicines and Healthcare Products Regulatory Agency (MHRA).
UN Food Crisis Summit Must Move Beyond Old Ineffective Recipes - MSF Calls For Reforms To Food Aid And Nutrition Programmes To Save Young Lives
As heads-of-state and nearly 20 key UN officials meet in Rome this week to design a plan to tackle the current global food crisis, M~A decins Sans Fronti~A"res (MSF) is urging the adoption and rapid scale-up of specific nutritional strategies that target children under two.
New Data From Several Satraplatin Clinical Trials In Solid Tumors Presented At 44th ASCO Annual Meeting
GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the presentation of data from several satraplatin clinical trials at the 44th Annual Meeting of the American Society for Clinical Oncology (ASCO) in Chicago.
Formed Think-Tank Seeks To Raise Awareness Among Healthcare Providers Of Underlying Neurobiological Link Between Various Disorders
A coalition of healthcare professionals have formed the Integrative Neurobiology Educational Alliance (INEA), a think-tank of national thought leaders who identify key educational gaps and needs from a neurobiological perspective.
ECRI Institute And Phoenix Data Systems To Offer CMMS Integration Package
New service helps hospitals with capital equipment inventory and patient safety alerts and recalls PLYMOUTH MEETING, PA - ECRI Institute, an independent nonprofit that researches the best approaches to improving patient care, and Phoenix Data Systems, Inc.